Alterations in the tumor immune microenvironment can also lead to primary drug resistance, such as the finding that tumor-associated macrophages can be recruited due to the effect of HDAC5 on chemokine, mediating SMAD4-dependent and KRAS-independent PDAC tumor growth [106]. This evidence concerns the gene SMAD4 and neoplasm.